Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Ann Nucl Med Retrieve available abstracts of 203 articles: HTML format

Single Articles

October 2025
1. RUZZEH S, Abdlkadir AS, Al-Alawi H, Lopci E, et al
   Evaluating the diagnostic utility of [(6)(8)Ga]Ga-Pentixafor in solid tumors: a systematic review.
   Ann Nucl Med. 2025;39:1053-1073.
   PubMed     Abstract available
   
   
   September 2025
2. LIU C, Song S
   Response to the comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
   Ann Nucl Med. 2025 Sep 23. doi: 10.1007/s12149-025-02110.
   PubMed    
   
   
   
3. LUE KH, Wang YH, Chen YH, Chu SC, et al
   The prognostic value of (18)F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy.
   Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02108.
   PubMed     Abstract available
   
   
   
4. HOSOKAWA T, Uchiyama M, Namba S, Tanami Y, et al
   Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data.
   Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02109.
   PubMed     Abstract available
   
   
   
5. IMAI M, Ochiai Y, Kosaka Y, Mori K, et al
   Impact of body weight on arterial partition coefficient estimation in (123)I-IMP SPECT: a comparison between ARG and no-arterial sampling methods.
   Ann Nucl Med. 2025 Sep 19. doi: 10.1007/s12149-025-02104.
   PubMed     Abstract available
   
   
   
6. NIFTALIYEVA K, Kesim S, Filizoglu N, Balaban Genc ZC, et al
   Interobserver and intraobserver agreement for equivocal lesions in Ga-68 PSMA PET/CT according to PSMA-RADS 2.0 criteria.
   Ann Nucl Med. 2025 Sep 10. doi: 10.1007/s12149-025-02103.
   PubMed     Abstract available
   
   
   
7. ABE K, Baba S, Etani R, Fujimto T, et al
   Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan.
   Ann Nucl Med. 2025 Sep 3. doi: 10.1007/s12149-025-02102.
   PubMed     Abstract available
   
   
   
8. CHEN Z, Wakabayashi H, Mori H, Hiromasa T, et al
   Dynamic expression of the myocardial sigma-1 receptor after doxorubicin cardiomyopathy using radioiodine-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5 V) imaging.
   Ann Nucl Med. 2025;39:973-981.
   PubMed     Abstract available
   
   
   August 2025
9. TANIMOTO K, Kawamura Y, Kimura S, Hasuike Y, et al
   SPECT reconstruction using preprocessing masking for extra-cardiac uptake versus standard processing in (99m)Tc-sestamibi myocardial perfusion imaging.
   Ann Nucl Med. 2025 Aug 26. doi: 10.1007/s12149-025-02085.
   PubMed     Abstract available
   
   
   
10. LI Y, Chen K, Jin L, Huang H, et al
    Development and validation of an (18)F-FDG PET/CT radiomic nomogram for predicting axillary lymph-node status after neoadjuvant chemotherapy for breast cancer: a multicenter study.
    Ann Nucl Med. 2025 Aug 17. doi: 10.1007/s12149-025-02099.
    PubMed     Abstract available
    
    
    
11. MA H, Li C, Zhang Q, Liu J, et al
    Diagnostic value of (18)F-FDG PET/CT in the follow-up of conjunctival melanoma.
    Ann Nucl Med. 2025 Aug 15. doi: 10.1007/s12149-025-02097.
    PubMed     Abstract available
    
    
    
12. SEBAN RD, Rebaud L, Djerroudi L, Vincent-Salomon A, et al
    Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?
    Ann Nucl Med. 2025 Aug 12. doi: 10.1007/s12149-025-02098.
    PubMed     Abstract available
    
    
    
13. YAMAZAKI K, Higashi T, Nishii R, Terada T, et al
    Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing (99 m)Tc-GSA scintigraphy prior to carbon-ion radiotherapy.
    Ann Nucl Med. 2025;39:781-791.
    PubMed     Abstract available
    
    
    
14. SOYDAS-TURAN B, Yalcin-Cakmakli G, Lay Ergun E, Dasgin H, et al
    Multimodal imaging analysis of autosomal recessive Parkinson's disease.
    Ann Nucl Med. 2025;39:813-822.
    PubMed     Abstract available
    
    
    
15. KOCAMAN G, Ibrahimov F, Kahya Y, Araz M, et al
    Suvmax of the lesion should be considered in the treatment plan for stage I non-small cell lung cancer.
    Ann Nucl Med. 2025;39:792-798.
    PubMed     Abstract available
    
    
    July 2025
16. CHEN J, Wang Q, Li Y, Song J, et al
    Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion.
    Ann Nucl Med. 2025 Jul 28. doi: 10.1007/s12149-025-02091.
    PubMed     Abstract available
    
    
    
17. WATABE T, Hirata K, Iima M, Yanagawa M, et al
    Recent advances in theranostics and oncology PET: emerging radionuclides and targets.
    Ann Nucl Med. 2025 Jul 27. doi: 10.1007/s12149-025-02090.
    PubMed     Abstract available
    
    
    
18. HINO A, Mizoguchi N, Koge H, Yaguchi R, et al
    Prognostic value of FDG-PET/CT findings in mucosal melanoma of the head and neck treated with carbon ion radiotherapy.
    Ann Nucl Med. 2025 Jul 25. doi: 10.1007/s12149-025-02069.
    PubMed     Abstract available
    
    
    
19. ITO K, Jinnouchi S, Kikukawa K, Okuyama C, et al
    Clinical Practice Guidelines for (18)F-Fluciclovine 2024 in the Japanese Society of Nuclear Medicine.
    Ann Nucl Med. 2025 Jul 25. doi: 10.1007/s12149-025-02089.
    PubMed     Abstract available
    
    
    
20. TOYAMA Y, Kotani T, Tamaki N, Yamada S, et al
    Distribution patterns of brown adipose tissue on FDG-PET/CT has age characteristics.
    Ann Nucl Med. 2025 Jul 24. doi: 10.1007/s12149-025-02087.
    PubMed     Abstract available
    
    
    
21. MIWA K, Yamao T, Hashimoto F, Miyaji N, et al
    Innovations in clinical PET image reconstruction: advances in Bayesian penalized likelihood algorithm and deep learning.
    Ann Nucl Med. 2025 Jul 18. doi: 10.1007/s12149-025-02088.
    PubMed     Abstract available
    
    
    
22. ENEI Y, Yanagisawa T, Okada A, Kuruma H, et al
    Comparison of diagnostic performance between manual diagnosis following PROMISE V2 and aPROMISE utilizing Ga/F-PSMA PET/CT.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02086.
    PubMed     Abstract available
    
    
    
23. HIRAOKA K, Mesfin B, Wu Y, Shimizu Y, et al
    Kinetic and quantitative analysis of [(18)F]SMBT-1 PET imaging for monoamine oxidase B.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02083.
    PubMed     Abstract available
    
    
    
24. ITO R, Kato K, Higashi M, Abe Y, et al
    Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02084.
    PubMed     Abstract available
    
    
    
25. WU S, Li C, Lu J, Ge J, et al
    PETFormer-SCL: a supervised contrastive learning-guided CNN-transformer hybrid network for Parkinsonism classification from FDG-PET.
    Ann Nucl Med. 2025 Jul 14. doi: 10.1007/s12149-025-02081.
    PubMed     Abstract available
    
    
    
26. KHAN D, Jaleel J, Phulia A, Sagar S, et al
    Diagnostic accuracy of 18F-FDG and 68 Ga-FAPi PET/CT for patients with gastric carcinoma: a systematic review and meta-analysis.
    Ann Nucl Med. 2025 Jul 11. doi: 10.1007/s12149-025-02082.
    PubMed     Abstract available
    
    
    
27. LI H, Li C, Tian Y, Xiao Z, et al
    Same-day dual-tracer PET/CT imaging with [(68) Ga]Ga-FAPI-04 following [(18)F]FDG finds answers in patients presenting with negative or equivocal [(18)F]FDG.
    Ann Nucl Med. 2025 Jul 4. doi: 10.1007/s12149-025-02080.
    PubMed     Abstract available
    
    
    
28. WAKABAYASHI N, Watanabe S, Takeuchi S, Tsuchikawa T, et al
    Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.
    Ann Nucl Med. 2025;39:696-706.
    PubMed     Abstract available
    
    
    
29. FILIZOGLU N, Ozguven S, Kesim S, Oksuzoglu K, et al
    Physiological bio-distribution of (68)Ga-DOTA-TATE in pediatric patients.
    Ann Nucl Med. 2025;39:650-662.
    PubMed     Abstract available
    
    
    June 2025
30. TAMURA K, Nishii R, Tsuji AB, Tsukada J, et al
    Prognostic value of pre-treatment metabolic tumor volume on [S?methyl?(11)C]?L?methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy.
    Ann Nucl Med. 2025 Jun 30. doi: 10.1007/s12149-025-02067.
    PubMed     Abstract available
    
    
    
31. LEE SW, Jeong SY, Kim SJ
    Diagnostic performance of FDG PET/CT radiomics in predicting microvascular invasion in hepatocellular carcinoma compared to conventional metabolic parameters: a systematic review and meta-analysis.
    Ann Nucl Med. 2025 Jun 28. doi: 10.1007/s12149-025-02075.
    PubMed     Abstract available
    
    
    
32. ZAMBRANO-INFANTINO RDC, Pinerua-Gonsalvez JF, Sebastian-Palacid F, Alvarez-Mena N, et al
    From image to index: diagnostic accuracy of a novel semi-quantitative approach for assessing suspected periprosthetic joint infection with triple-phase bone scintigraphy.
    Ann Nucl Med. 2025 Jun 26. doi: 10.1007/s12149-025-02076.
    PubMed     Abstract available
    
    
    
33. LIU C, Pan D, Sun Y, Xu X, et al
    The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study.
    Ann Nucl Med. 2025 Jun 26. doi: 10.1007/s12149-025-02071.
    PubMed     Abstract available
    
    
    
34. OMASA W, Matsumoto K, Shimizu K, Ohara N, et al
    Measurement accuracy and practicality of (15)O-gas PET using a high-sensitivity whole-body PET/CT scanner.
    Ann Nucl Med. 2025 Jun 25. doi: 10.1007/s12149-025-02073.
    PubMed     Abstract available
    
    
    
35. TAN X, Zhou Y, Zhang Q, Yuan H, et al
    Assessment of reduced (18)F-FDG dosage in pediatric PET/MR imaging through randomized down-sampling.
    Ann Nucl Med. 2025 Jun 17. doi: 10.1007/s12149-025-02066.
    PubMed     Abstract available
    
    
    
36. HE X, Li J, Wang L, Xie Y, et al
    A comparative study of dual-layer spectral CT and 18F-FDG-PET/CT multi-quantitative parameters in the diagnosis of sentinel lymph nodes in breast cancer.
    Ann Nucl Med. 2025 Jun 17. doi: 10.1007/s12149-025-02074.
    PubMed     Abstract available
    
    
    
37. FUKUI Y, Baba S, Ohashi K, Nagatani Y, et al
    Evaluation of the feasibility of anomaly detection for dose management in PET examinations.
    Ann Nucl Med. 2025 Jun 16. doi: 10.1007/s12149-025-02063.
    PubMed     Abstract available
    
    
    
38. CHAREST M, Belair MA
    From planar to SPECT-CT brain perfusion study in brain death determination: our experience from 2010 to 2023.
    Ann Nucl Med. 2025 Jun 15. doi: 10.1007/s12149-025-02068.
    PubMed     Abstract available
    
    
    
39. SHIRAI Y, Nagao M, Inoue A, Yamamoto A, et al
    Diagnosis of cardiac sarcoidosis using glucose metabolic rate from four-dimensional (18)F-FDG PET/CT.
    Ann Nucl Med. 2025 Jun 14. doi: 10.1007/s12149-025-02070.
    PubMed     Abstract available
    
    
    
40. ZHANG X, Nakajima K, Acampa W, Assante R, et al
    Establishment of a (123)I-meta-iodobenzylguanidine normal database for D-SPECT using Japanese and Italian data.
    Ann Nucl Med. 2025 Jun 2. doi: 10.1007/s12149-025-02061.
    PubMed     Abstract available
    
    
    
41. LIU YS, Wang L, Song HY, Wang L, et al
    Radiomics of lung ventilation/perfusion tomographic imaging in pulmonary embolism diagnosis.
    Ann Nucl Med. 2025;39:608-617.
    PubMed     Abstract available
    
    
    May 2025
42. SCHAEBEL GH, Johannesen HH, Lofgren J, Gutte H, et al
    The prognostic value of positron emission tomography/magnetic resonance imaging in predicting survival in patients with adenocarcinoma of the esophagogastric junction.
    Ann Nucl Med. 2025 May 17. doi: 10.1007/s12149-025-02058.
    PubMed     Abstract available
    
    
    
43. TAMURA K, Tsuji AB, Nishii R, Tani K, et al
    A first-in-man PET study of 2-amino-[3-(11)C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers.
    Ann Nucl Med. 2025 May 13. doi: 10.1007/s12149-025-02059.
    PubMed     Abstract available
    
    
    
44. HUA Q, Wang N, Wang D, Wen J, et al
    Feasibility and mechanism of (68)Ga-FAPI PET/CT in monitoring chemoresistance of non-small cell lung cancer.
    Ann Nucl Med. 2025 May 11. doi: 10.1007/s12149-025-02056.
    PubMed     Abstract available
    
    
    
45. WANG K, Wang X, Meng X, Zhang G, et al
    Molecular imaging using (18)F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB NSCLC.
    Ann Nucl Med. 2025 May 10. doi: 10.1007/s12149-025-02057.
    PubMed     Abstract available
    
    
    
46. ROSHANRAVAN V, Ghorbani H, Soltani S, Shabani E, et al
    The diagnostic value of whole-body HYNIC-PSMA 11 -Tc [(99 m)Tc] SPECT/CT scan in early staging of patients with moderate- and high-risk prostate cancer.
    Ann Nucl Med. 2025 May 10. doi: 10.1007/s12149-025-02055.
    PubMed     Abstract available
    
    
    
47. LU J, Chen K, Lin H, Ju Z, et al
    Phenotype-specific metabolic patterns in Posterior cortical atrophy and early-onset typical Alzheimer's disease.
    Ann Nucl Med. 2025;39:506-517.
    PubMed     Abstract available
    
    
    
48. AKGUN E, Erdim C, Ibicioglu B, Guzelbey T, et al
    Is there any effect of hcc location on selective internal radiation therapy with (90)yttrium response?
    Ann Nucl Med. 2025;39:527-534.
    PubMed     Abstract available
    
    
    
49. OYA A, Nakayama M, Uno T, Ueda H, et al
    Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras.
    Ann Nucl Med. 2025;39:466-475.
    PubMed     Abstract available
    
    
    April 2025
50. KOBATA T, Norikane T, Murao M, Manabe Y, et al
    Test for shortening the computation time for imaging of appearance time for cerebral blood using H(2)(15)O and positron emission tomography.
    Ann Nucl Med. 2025 Apr 29. doi: 10.1007/s12149-025-02054.
    PubMed     Abstract available
    
    
    
51. YAMAKUNI R, Abe M, Ukon N, Matsuda H, et al
    Comparison and cutoff values of two amyloid PET scaling methods: centiloid scale and amyloid-beta load.
    Ann Nucl Med. 2025 Apr 26. doi: 10.1007/s12149-025-02051.
    PubMed     Abstract available
    
    
    
52. DEMIR B, Kucuk NO, Soydal C, Celebioglu EC, et al
    Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres.
    Ann Nucl Med. 2025 Apr 23. doi: 10.1007/s12149-025-02052.
    PubMed     Abstract available
    
    
    
53. TAKEMOTO S, Onuki K, Tanimoto K, Taniguchi M, et al
    Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using (18)F-flutemetamol.
    Ann Nucl Med. 2025 Apr 19. doi: 10.1007/s12149-025-02046.
    PubMed     Abstract available
    
    
    
54. MATSUTOMO N, Fukami M, Yamamoto T
    Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?
    Ann Nucl Med. 2025 Apr 16. doi: 10.1007/s12149-025-02047.
    PubMed     Abstract available
    
    
    
55. HOTTA M, Horikawa D, Kurihara K, Ohashi S, et al
    Pre-treatment (111)In-pentetreotide SPECT/CT vs. baseline (177)Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?
    Ann Nucl Med. 2025 Apr 14. doi: 10.1007/s12149-025-02050.
    PubMed     Abstract available
    
    
    
56. PEI Y, Tong Y, Wang Z, Qiao X, et al
    Analysis of the best time-point for 18F-FDG PET/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values.
    Ann Nucl Med. 2025 Apr 2. doi: 10.1007/s12149-025-02045.
    PubMed     Abstract available
    
    
    
57. ZHANG Z, Ma Z, Wang X, Zhou Y, et al
    Specific molecular imaging of BALB/c model mice with Graves' ophthalmopathy based on high expression of insulin-like growth factor 1 receptor.
    Ann Nucl Med. 2025;39:388-397.
    PubMed     Abstract available
    
    
    
58. LIU Y, Wang F, Song Y, Zhou X, et al
    First study on the efficiency of (99m)Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.
    Ann Nucl Med. 2025;39:380-387.
    PubMed     Abstract available
    
    
    
59. LIM CH, Lee JH, Lee J, Park SB, et al
    Predictive value of (18)F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes.
    Ann Nucl Med. 2025;39:315-322.
    PubMed     Abstract available
    
    
    March 2025
60. LU D, Zhu X, Mu X, Huang X, et al
    Development and validation of a nomogram for predicting bone marrow involvement in lymphoma patients based on (18)F-FDG PET radiomics and clinical factors.
    Ann Nucl Med. 2025 Mar 29. doi: 10.1007/s12149-025-02041.
    PubMed     Abstract available
    
    
    
61. BUDDENKOTTE T, Lange C, Klutmann S, Apostolova I, et al
    Fully automatic categorical analysis of striatal subregions in dopamine transporter SPECT using a convolutional neural network.
    Ann Nucl Med. 2025 Mar 16. doi: 10.1007/s12149-025-02038.
    PubMed     Abstract available
    
    
    
62. HUANG S, Zhang Y, Zhang W, Tian T, et al
    Metabolic tumor parameters on (18)F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.
    Ann Nucl Med. 2025 Mar 15. doi: 10.1007/s12149-025-02039.
    PubMed     Abstract available
    
    
    
63. RAINIO O, Karpijoki H, Knuuti J, Klen R, et al
    Pulmonary blood flow quantification in humans from 15O-water PET.
    Ann Nucl Med. 2025 Mar 14. doi: 10.1007/s12149-025-02035.
    PubMed     Abstract available
    
    
    
64. ZHANG MX, Liu PF, Zhang MD, Su PG, et al
    Deep learning in nuclear medicine: from imaging to therapy.
    Ann Nucl Med. 2025 Mar 13. doi: 10.1007/s12149-025-02031.
    PubMed     Abstract available
    
    
    
65. GARCIA MEGIAS I, Almeida LS, Calapaqui Teran AK, Pabst KM, et al
    FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?
    Ann Nucl Med. 2025 Mar 11. doi: 10.1007/s12149-025-02022.
    PubMed     Abstract available
    
    
    
66. WANG M, Quan Z, Xin K, Li G, et al
    Superiority of (68)Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting.
    Ann Nucl Med. 2025 Mar 11. doi: 10.1007/s12149-025-02033.
    PubMed     Abstract available
    
    
    
67. GAUTHAMAN DK, Muthukrishnan I, Acharya KA, Simon S, et al
    Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study.
    Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02036.
    PubMed     Abstract available
    
    
    
68. MU X, Zhu Z, Wang Z, Li X, et al
    Insights into lung cancer diagnosis and clinical management using [(18)F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT).
    Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02032.
    PubMed     Abstract available
    
    
    
69. MORI Y, Tamburini K, Novruzov E, Schmitt D, et al
    Efficacy of [(68)Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis.
    Ann Nucl Med. 2025 Mar 6. doi: 10.1007/s12149-025-02027.
    PubMed     Abstract available
    
    
    
70. LIU H, Meng X, Wang G, Yao S, et al
    Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT.
    Ann Nucl Med. 2025 Mar 5. doi: 10.1007/s12149-025-02034.
    PubMed     Abstract available
    
    
    
71. KATAHIRA M, Fukushima K, Endo K, Kawakubo M, et al
    Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid (13)N ammonia PETMR system.
    Ann Nucl Med. 2025;39:285-294.
    PubMed     Abstract available
    
    
    
72. AGGARWAL P, Gunasekaran V, Gowtham M, Mahajan JK, et al
    Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by (99m)Tc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging.
    Ann Nucl Med. 2025;39:266-272.
    PubMed     Abstract available
    
    
    February 2025
73. WU H, Liu G, Ruan X, Zhang B, et al
    A low-dose protocol in pediatric (18)F-FDG scans using 30-cm axis field of view PET/CT.
    Ann Nucl Med. 2025 Feb 28. doi: 10.1007/s12149-025-02030.
    PubMed     Abstract available
    
    
    
74. ALBANO D, Temponi A, Bertagna F, Suardi N, et al
    The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer.
    Ann Nucl Med. 2025 Feb 17. doi: 10.1007/s12149-025-02026.
    PubMed     Abstract available
    
    
    
75. JIMENEZ LONDONO GA, Perez-Beteta J, Amo-Salas M, Honguero-Martinez AF, et al
    Clinicopathologic and metabolic variables from (18)F-FDG PET/CT in the prediction of recurrence pattern in stage I-III non-small cell lung cancer after curative surgery.
    Ann Nucl Med. 2025 Feb 13. doi: 10.1007/s12149-025-02021.
    PubMed     Abstract available
    
    
    
76. HIRATA K, Matsui Y, Yamada A, Fujioka T, et al
    Correction: Generative AI and large language models in nuclear medicine: current status and future prospects.
    Ann Nucl Med. 2025 Feb 11. doi: 10.1007/s12149-025-02024.
    PubMed    
    
    
    
77. ABD-ELKADER MS, Elmaghraby SM, Abdel-Mohsen MA, Khalil MM, et al
    Correction: Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.
    Ann Nucl Med. 2025 Feb 2. doi: 10.1007/s12149-025-02019.
    PubMed    
    
    
    
78. KINUYA S
    Congratulations on the 60th anniversary of the Japanese Society of Nuclear Medicine.
    Ann Nucl Med. 2025 Feb 1. doi: 10.1007/s12149-024-02008.
    PubMed     Abstract available
    
    
    
79. HUANG J, Li J, Li Z, Qin J, et al
    Assessing osteoporosis and bone mineral density through (18)F-NaF uptake at lumbar spine.
    Ann Nucl Med. 2025;39:150-157.
    PubMed     Abstract available
    
    
    January 2025
80. MATSUDA H, Hanyu H, Kaneko C, Ogura M, et al
    Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients.
    Ann Nucl Med. 2025 Jan 28. doi: 10.1007/s12149-025-02018.
    PubMed     Abstract available
    
    
    
81. TATSUMI M, Morita N, Kida A, Momoi R, et al
    Effects of data-driven respiratory gating on visualization and quantification of breast and upper abdominal cancers in FDG PET/CT examinations.
    Ann Nucl Med. 2025 Jan 23. doi: 10.1007/s12149-025-02017.
    PubMed     Abstract available
    
    
    
82. RAINIO O, Klen R
    Compartmental modeling for blood flow quantification from dynamic 15 O-water PET images of humans: a systematic review.
    Ann Nucl Med. 2025 Jan 20. doi: 10.1007/s12149-025-02014.
    PubMed     Abstract available
    
    
    
83. ZHANG G, Shen J, Hu T, Zheng W, et al
    Utility of (18)F-FDG PET/CT metabolic parameters on post-transplant lymphoproliferative disorder diagnosis.
    Ann Nucl Med. 2025 Jan 18. doi: 10.1007/s12149-025-02016.
    PubMed     Abstract available
    
    
    
84. GUGLIELMO P, Buffi N, Porreca A, Setti L, et al
    Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
    Ann Nucl Med. 2025 Jan 15. doi: 10.1007/s12149-025-02015.
    PubMed     Abstract available
    
    
    
85. ROSHAN A, Pasha T, Kounidas G, Murphy S, et al
    Next day sentinel node biopsy for melanoma after lymphoscintigraphy using (99m)Tc-labelled nanocolloid does not adversely affect long-term outcomes.
    Ann Nucl Med. 2025;39:77-85.
    PubMed     Abstract available
    
    
    
86. YAMA N, Tatsumi H, Akatsuka M, Hatakenaka M, et al
    Blood-pool SUV analysis of 99mTc-galactosyl human serum albumin (99mTc-GSA) normalized by blood volume for prediction of short-term survival in severe liver failure: preliminary report.
    Ann Nucl Med. 2025;39:58-67.
    PubMed     Abstract available
    
    
    December 2024
87. DE RUITER RD, Zwama J, Raijmakers PGHM, Yaqub M, et al
    Validation of quantitative [(18)F]NaF PET uptake parameters in bone diseases: a systematic review.
    Ann Nucl Med. 2024 Dec 27. doi: 10.1007/s12149-024-01991.
    PubMed     Abstract available
    
    
    
88. OKUYAMA C, Inuzuka Y, Takeuchi Y, Asagoe K, et al
    Imaging of cardiac amyloidosis using dynamic (18)F-FPYBF-2 positron emission tomography.
    Ann Nucl Med. 2024 Dec 20. doi: 10.1007/s12149-024-02010.
    PubMed     Abstract available
    
    
    
89. LI S, Sang B, Liu J, Liu Y, et al
    Application of modified Curie and SIOPEN skeleton scoring systems in (18)F-AlF-NOTA-octreotide PET/CT for neuroblastoma.
    Ann Nucl Med. 2024 Dec 15. doi: 10.1007/s12149-024-02006.
    PubMed     Abstract available
    
    
    
90. ZHOU X, Yan S, Li D, Zhu H, et al
    Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.
    Ann Nucl Med. 2024 Dec 14. doi: 10.1007/s12149-024-02009.
    PubMed     Abstract available
    
    
    
91. SAGARA H, Inoue K, Mano C, Kajiwara H, et al
    Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests.
    Ann Nucl Med. 2024 Dec 7. doi: 10.1007/s12149-024-02007.
    PubMed     Abstract available
    
    
    
92. FUJII H, Toyama H, Kayano D, Ishii K, et al
    The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMB.
    Ann Nucl Med. 2024 Dec 2. doi: 10.1007/s12149-024-01999.
    PubMed     Abstract available
    
    
    
93. SHIN S, Nam HY, Kim K, Kim J, et al
    Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson's disease: a Bayesian approach.
    Ann Nucl Med. 2024;38:989-998.
    PubMed     Abstract available
    
    
    November 2024
94. CHAN SC, Chiu TL, Ng SH, Kao HW, et al
    (18)F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.
    Ann Nucl Med. 2024 Nov 26. doi: 10.1007/s12149-024-02005.
    PubMed     Abstract available
    
    
    
95. USLU H, Sahin D, Ibisoglu E, Tatoglu MT, et al
    PRIMARY scoring in 68Ga-PSMA PET/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance.
    Ann Nucl Med. 2024 Nov 23. doi: 10.1007/s12149-024-02004.
    PubMed     Abstract available
    
    
    
96. WATANABE T, Baba A, Fukuda T, Watanabe K, et al
    Role of visual information in multimodal large language model performance: an evaluation using the Japanese nuclear medicine board examination.
    Ann Nucl Med. 2024 Nov 13. doi: 10.1007/s12149-024-01992.
    PubMed     Abstract available
    
    
    
97. AMASHA AAH, Kasalak O, Glaudemans AWJM, Noordzij W, et al
    Increased individual workload for nuclear medicine physicians over the past years: 2008-2023 data from The Netherlands.
    Ann Nucl Med. 2024 Nov 10. doi: 10.1007/s12149-024-01995.
    PubMed     Abstract available
    
    
    
98. SUN X, Zhang G, Zhang Q, Yuan H, et al
    Comparison of early and standard (18)F-PSMA-11 PET/CT imaging in treatment-naive patients with prostate cancer.
    Ann Nucl Med. 2024 Nov 10. doi: 10.1007/s12149-024-02000.
    PubMed     Abstract available
    
    
    
99. NAKAMOTO Y, Inui Y, Hotta M, Wakabayashi H, et al
    Recent advancements in new tracers from first-in-human studies.
    Ann Nucl Med. 2024;38:877-883.
    PubMed     Abstract available
    
    
    
100. TAKAI G, Hanaoka K, Nagano K, Okada T, et al
     Prediction of 1 cm dose-equivalent rate on the day after administration of (177)Lu-DOTATATE from (111)In-somatostatine receptor scintigraphy prior to treatment.
     Ann Nucl Med. 2024;38:927-932.
     PubMed     Abstract available
     
     
     
101. LING SW, van der Veldt A, Segbers M, Luiting H, et al
     Tubarial salivary glands show a low relative contribution to functional salivary gland tissue mass.
     Ann Nucl Med. 2024;38:913-918.
     PubMed     Abstract available
     
     
     
102. HANDAYANI W, Chantadisai M, Phromphao B, Noipinit N, et al
     Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment.
     Ann Nucl Med. 2024;38:884-893.
     PubMed     Abstract available
     
     
     October 2024
103. SASAKI Y
     The 1st World Congress of Nuclear Medicine and Biology held in Japan: a historical review with personal reminiscences.
     Ann Nucl Med. 2024 Oct 30. doi: 10.1007/s12149-024-01988.
     PubMed     Abstract available
     
     
     
104. WATANABE M, Fendler WP, Grafe H, Hirmas N, et al
     Head-to-head comparison of (68) Ga-FAPI-46 PET/CT, (18)F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors.
     Ann Nucl Med. 2024 Oct 23. doi: 10.1007/s12149-024-01993.
     PubMed     Abstract available
     
     
     
105. ABD-ELKADER MS, Elmaghraby SM, Abdel-Mohsen MA, Khalil MM, et al
     Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.
     Ann Nucl Med. 2024 Oct 16. doi: 10.1007/s12149-024-01985.
     PubMed     Abstract available
     
     
     
106. SHAGERA QA, Gil T, Barraco E, Boegner P, et al
     Evaluating response to radium-223 using (68)Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer.
     Ann Nucl Med. 2024 Oct 5. doi: 10.1007/s12149-024-01990.
     PubMed     Abstract available
     
     
     
107. DAUNGSUPAWONG H, Wiwanitkit V
     Impact of recent COVID-19 infection on perfusion and functional parameters derived from gated myocardial perfusion imaging in patients undergoing evaluation for coronary artery disease: correspondence.
     Ann Nucl Med. 2024;38:852.
     PubMed    
     
     
     
108. KAPLAN I, Komek H, Can C, Akdeniz N, et al
     Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?
     Ann Nucl Med. 2024;38:825-834.
     PubMed     Abstract available
     
     
     
109. ALVANDI M, Shaghaghi Z, Fatehi Z, Naghshtabrizi B, et al
     Exploring the impact of recent COVID-19 infection on perfusion and functional parameters derived from gated myocardial perfusion imaging in patients undergoing evaluation for coronary artery disease.
     Ann Nucl Med. 2024;38:789-794.
     PubMed     Abstract available
     
     
     September 2024
110. YAMADA T, Hanaoka K, Morimoto-Ishikawa D, Yamakawa Y, et al
     Crossover evaluation of time-of-flight-based attenuation correction in brain (18)F-FDG and (18)F-flutemetamol PET.
     Ann Nucl Med. 2024 Sep 30. doi: 10.1007/s12149-024-01986.
     PubMed     Abstract available
     
     
     
111. BOKTOR RR, Berlangieri SU, Lau E, Lim A, et al
     (18)F-FDG PET/CT biomarkers as predictors of long term outcomes and survival rates in patients with high risk malignant pulmonary masses/nodules treated with stereotactic ablative radiotherapy.
     Ann Nucl Med. 2024 Sep 28. doi: 10.1007/s12149-024-01983.
     PubMed     Abstract available
     
     
     
112. HIRATA K, Matsui Y, Yamada A, Fujioka T, et al
     Generative AI and large language models in nuclear medicine: current status and future prospects.
     Ann Nucl Med. 2024 Sep 25. doi: 10.1007/s12149-024-01981.
     PubMed     Abstract available
     
     
     
113. TAKENAKA A, Nihashi T, Sakurai K, Notomi K, et al
     Interrater agreement and variability in visual reading of [18F] flutemetamol PET images.
     Ann Nucl Med. 2024 Sep 24. doi: 10.1007/s12149-024-01977.
     PubMed     Abstract available
     
     
     
114. BELGE BILGIN G, Bilgin C, Orscelik A, Burkett BJ, et al
     Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis.
     Ann Nucl Med. 2024 Sep 17. doi: 10.1007/s12149-024-01978.
     PubMed     Abstract available
     
     
     
115. JIA Y, Hu Y, Yang L, Diao X, et al
     Prognostic value of transient ischemic dilatation by (13)N-ammonia PET MPI for short-term outcomes in patients with non-obstructive CAD.
     Ann Nucl Med. 2024 Sep 9. doi: 10.1007/s12149-024-01976.
     PubMed     Abstract available
     
     
     
116. KANAYA H, Shiraishi S, Ogasawara K, Iwashita K, et al
     Inverse correlation between age of onset and myocardial amyloid deposition quantified by (99m)Tc-PYP scintigraphy in patients with wild-type transthyretin amyloid cardiomyopathy.
     Ann Nucl Med. 2024;38:744-753.
     PubMed     Abstract available
     
     
     
117. WANG N, Qu S, Kong W, Hua Q, et al
     Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics.
     Ann Nucl Med. 2024;38:734-743.
     PubMed     Abstract available
     
     
     
118. HOSOKAWA T, Uchiyama M, Tanami Y, Sato Y, et al
     Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia.
     Ann Nucl Med. 2024;38:711-725.
     PubMed     Abstract available
     
     
     August 2024
119. GELBART E, Krakovich A, Sherm Y, Rabin G, et al
     Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom.
     Ann Nucl Med. 2024 Aug 30. doi: 10.1007/s12149-024-01966.
     PubMed     Abstract available
     
     
     
120. KISO K, Nakajima K, Nimura Y, Nishimura T, et al
     A novel algorithm developed using machine learning and a J-ACCESS database can estimate defect scores from myocardial perfusion single-photon emission tomography images.
     Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01971.
     PubMed     Abstract available
     
     
     
121. TSUZURA K, Wagatsuma K, Kamitaka Y, Miwa K, et al
     Phantom test procedures for a new neuro-oncological amino acid PET tracer: [(18)F]fluciclovine.
     Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01973.
     PubMed     Abstract available
     
     
     
122. DEMIR B, Soydal C, Kucuk NO, Celebioglu EC, et al
     Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres.
     Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01974.
     PubMed     Abstract available
     
     
     
123. XIN K, Ma X, Meng X, Zhang X, et al
     Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China.
     Ann Nucl Med. 2024 Aug 26. doi: 10.1007/s12149-024-01970.
     PubMed     Abstract available
     
     
     
124. SERAPHIM DM, Koga KH, Vacavant A, de Pina DR, et al
     How anatomical impairments found on CT affect perfusion percentage assessed by SPECT/CT scan?
     Ann Nucl Med. 2024 Aug 24. doi: 10.1007/s12149-024-01969.
     PubMed     Abstract available
     
     
     
125. MIZUMURA S, Tamamura N, Ebina J, Watanabe H, et al
     Quantitative evaluation of striatal uptake ratios using an adaptive template registration method for (123)I-ioflupane dopamine transporter SPECT.
     Ann Nucl Med. 2024 Aug 19. doi: 10.1007/s12149-024-01968.
     PubMed     Abstract available
     
     
     
126. HOU X, He Y, Liu G, Chen S, et al
     SPECT/CT imaging: quantifying (99m)Tc-MDP concentration in the spine and pelvis.
     Ann Nucl Med. 2024 Aug 18. doi: 10.1007/s12149-024-01967.
     PubMed     Abstract available
     
     
     
127. YAP WK, Hsu KH, Wang TH, Lin CH, et al
     The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.
     Ann Nucl Med. 2024;38:607-618.
     PubMed     Abstract available
     
     
     
128. JELTEMA HR, van Dijken BRJ, Tamasi K, Drost G, et al
     (11)C-Methionine uptake in meningiomas after stereotactic radiotherapy.
     Ann Nucl Med. 2024;38:596-606.
     PubMed     Abstract available
     
     
     July 2024
129. WUMENER X, Zhang Y, Zang Z, Ye X, et al
     The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
     Ann Nucl Med. 2024 Jul 29. doi: 10.1007/s12149-024-01964.
     PubMed     Abstract available
     
     
     
130. MIRBOD M, Ayubcha C, Redden HWK, Teichner E, et al
     FDG-PET in the diagnosis of primary progressive aphasia: a systematic review.
     Ann Nucl Med. 2024 Jul 19. doi: 10.1007/s12149-024-01958.
     PubMed     Abstract available
     
     
     
131. ARCAY OZTURK A, Erkilic M, Bural GG, Aydin F, et al
     Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution.
     Ann Nucl Med. 2024 Jul 9. doi: 10.1007/s12149-024-01957.
     PubMed     Abstract available
     
     
     
132. SHIMIZU Y, Ando M, Watanabe H, Ono M, et al
     Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.
     Ann Nucl Med. 2024 Jul 8. doi: 10.1007/s12149-024-01959.
     PubMed     Abstract available
     
     
     
133. COSKUN N, Kartal MO, Kartal AS, Cayhan V, et al
     Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres.
     Ann Nucl Med. 2024;38:525-533.
     PubMed     Abstract available
     
     
     
134. YIN H, Liu G, Mao W, Lv J, et al
     Parametric net influx rate imaging of (68)Ga-DOTATATE in patients with neuroendocrine tumors: assessment of lesion detectability.
     Ann Nucl Med. 2024;38:483-492.
     PubMed     Abstract available
     
     
     June 2024
135. OKUYAMA C, Higashi T, Ishizu K, Oishi N, et al
     New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.
     Ann Nucl Med. 2024 Jun 22. doi: 10.1007/s12149-024-01956.
     PubMed     Abstract available
     
     
     
136. YAMAKUNI R, Murakami T, Ukon N, Kakamu T, et al
     Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
     Ann Nucl Med. 2024 Jun 20. doi: 10.1007/s12149-024-01955.
     PubMed     Abstract available
     
     
     
137. 
     Correction to: Annals of Nuclear Medicine.
     Ann Nucl Med. 2024 Jun 19. doi: 10.1007/s12149-024-01953.
     PubMed    
     
     
     
138. LIANG H, Tan W, Wang J, Li M, et al
     Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma.
     Ann Nucl Med. 2024 Jun 14. doi: 10.1007/s12149-024-01949.
     PubMed     Abstract available
     
     
     
139. JAFARITADI M, Teuho J, Lehtonen E, Klen R, et al
     Deep generative denoising networks enhance quality and accuracy of gated cardiac PET data.
     Ann Nucl Med. 2024 Jun 6. doi: 10.1007/s12149-024-01945.
     PubMed     Abstract available
     
     
     
140. TAKAHASHI K, Manabe O, Shizukuishi K, Shibata H, et al
     Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
     Ann Nucl Med. 2024;38:409-417.
     PubMed     Abstract available
     
     
     
141. CHIMURA M, Ohtani T, Sera F, Higuchi R, et al
     Novel indices representing heterogeneous distributions of myocardial perfusion imaging.
     Ann Nucl Med. 2024;38:468-474.
     PubMed     Abstract available
     
     
     
142. LI Y, Yang Z, Yin P, Gao X, et al
     Quantitative analysis of abdominal aortic blood flow by (99m)Tc-DTPA renal scintigraphy in patients with heart failure.
     Ann Nucl Med. 2024;38:418-427.
     PubMed     Abstract available
     
     
     May 2024
143. MIYAJIMA I, Yoshikawa A, Sahashi K, Seki C, et al
     DOCK-PET: database of CNS kinetic parameters in the healthy human brain for existing PET tracers.
     Ann Nucl Med. 2024 May 30. doi: 10.1007/s12149-024-01947.
     PubMed     Abstract available
     
     
     
144. MOON JW, Song YH, Kim YN, Woo JY, et al
     [(18)F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings-a bicenter retrospective study.
     Ann Nucl Med. 2024 May 25. doi: 10.1007/s12149-024-01944.
     PubMed     Abstract available
     
     
     
145. BURASOTHIKUL P, Navikhacheevin C, Pasawang P, Sontrapornpol T, et al
     Dual-time-point dynamic (68)Ga-PSMA-11 PET/CT for parametric imaging generation in prostate cancer.
     Ann Nucl Med. 2024 May 18. doi: 10.1007/s12149-024-01939.
     PubMed     Abstract available
     
     
     
146. NAKAMOTO R, Yakami M, Nobashi TW, Isoda H, et al
     The effect of hormone therapy on physiological uptake of the endometrium on [(18)F]F-FDG PET in postmenopausal women.
     Ann Nucl Med. 2024 May 18. doi: 10.1007/s12149-024-01941.
     PubMed     Abstract available
     
     
     
147. INAKI A, Mizokami A, Wakabayashi H, Izumi K, et al
     Evaluation of (68)Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer.
     Ann Nucl Med. 2024 May 16. doi: 10.1007/s12149-024-01931.
     PubMed     Abstract available
     
     
     
148. DATTA D, Selvakumar B, Goel AD, Chhibber S, et al
     Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis.
     Ann Nucl Med. 2024 May 15. doi: 10.1007/s12149-024-01934.
     PubMed     Abstract available
     
     
     
149. TOMONARI Y, Onishi Y, Hashimoto F, Ote K, et al
     Animal PET scanner with a large field of view is suitable for high-throughput scanning of rodents.
     Ann Nucl Med. 2024 May 8. doi: 10.1007/s12149-024-01937.
     PubMed     Abstract available
     
     
     
150. LUE KH, Chen YH, Chu SC, Lin CB, et al
     Prognostic value of combining clinical factors, (18)F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation st
     Ann Nucl Med. 2024 May 5. doi: 10.1007/s12149-024-01936.
     PubMed     Abstract available
     
     
     
151. LIU M, Yao A, Li Z, Zhang J, et al
     Properties of [(18)F]FAPI monitoring of acute radiation pneumonia versus [(18)F]FDG in mouse models.
     Ann Nucl Med. 2024;38:360-368.
     PubMed     Abstract available
     
     
     
152. JI X, Zhu G, Gou J, Chen S, et al
     A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy.
     Ann Nucl Med. 2024;38:382-390.
     PubMed     Abstract available
     
     
     April 2024
153. ARAK H, Elboga U, Cayirli YB, Aytekin A, et al
     Prognostic significance of (68) Ga-FAPI PET/CT in patients with bone metastases in various cancers.
     Ann Nucl Med. 2024 Apr 30. doi: 10.1007/s12149-024-01935.
     PubMed     Abstract available
     
     
     
154. USMANI S, Ahmed N, Gnanasegaran G, Marafi F, et al
     Assessment of regional and total skeletal metabolism using (18)F-NaF PET/CT in patients with chronic kidney disease.
     Ann Nucl Med. 2024 Apr 27. doi: 10.1007/s12149-024-01929.
     PubMed     Abstract available
     
     
     
155. SUNG C, Oh JS, Park BS, Kim SS, et al
     Diagnostic performance of a deep-learning model using (18)F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer.
     Ann Nucl Med. 2024 Apr 8. doi: 10.1007/s12149-024-01925.
     PubMed     Abstract available
     
     
     
156. HOSSEINI SA, Shiri I, Ghaffarian P, Hajianfar G, et al
     The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods.
     Ann Nucl Med. 2024 Apr 4. doi: 10.1007/s12149-024-01923.
     PubMed     Abstract available
     
     
     
157. GUO H, Wu S, Xiang X, Wang S, et al
     Performance of (99m)Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.
     Ann Nucl Med. 2024;38:288-295.
     PubMed     Abstract available
     
     
     March 2024
158. JIN L, Zhang L, Fu L, Song F, et al
     18F-FDG PET/CT metabolism multi-parameter prediction of chemotherapy efficacy in locally progressive gastric cancer.
     Ann Nucl Med. 2024 Mar 27. doi: 10.1007/s12149-024-01921.
     PubMed     Abstract available
     
     
     
159. FUKAI S, Daisaki H, Umeda T, Shimada N, et al
     Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
     Ann Nucl Med. 2024 Mar 22. doi: 10.1007/s12149-024-01918.
     PubMed     Abstract available
     
     
     
160. SHANG C, Sakurai K, Nihashi T, Arahata Y, et al
     Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.
     Ann Nucl Med. 2024 Mar 21. doi: 10.1007/s12149-024-01919.
     PubMed     Abstract available
     
     
     
161. LEE K, Han S, Ryu J, Cho SG, et al
     Prognostic value of left ventricular mechanical dyssynchrony indices derived from gated myocardial perfusion SPECT in coronary artery disease: a systematic review and meta-analysis.
     Ann Nucl Med. 2024 Mar 18. doi: 10.1007/s12149-024-01915.
     PubMed     Abstract available
     
     
     
162. MARUO A, Magota K, Munakata Y, Hirata K, et al
     Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with (15)O-water.
     Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01913.
     PubMed     Abstract available
     
     
     
163. ZHANG X, Nakajima K, Mizokami A, Horikoshi H, et al
     Flare phenomenon visualized by (99m)Tc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer.
     Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01914.
     PubMed     Abstract available
     
     
     
164. WAGATSUMA K, Ikemoto K, Inaji M, Kamitaka Y, et al
     Impact of [(11)C]methionine PET with Bayesian penalized likelihood reconstruction on glioma grades based on new WHO 2021 classification.
     Ann Nucl Med. 2024 Mar 11. doi: 10.1007/s12149-024-01911.
     PubMed     Abstract available
     
     
     
165. MIYAMOTO M, Okuyama C, Kagawa S, Kusano K, et al
     Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
     Ann Nucl Med. 2024 Mar 7. doi: 10.1007/s12149-024-01917.
     PubMed    
     
     
     
166. OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
     The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression.
     Ann Nucl Med. 2024 Mar 2. doi: 10.1007/s12149-024-01910.
     PubMed     Abstract available
     
     
     
167. NOIPINIT N, Sukprakun C, Siricharoen P, Khamwan K, et al
     Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing (99m)Tc-MAA and (90)Y-microspheres radioembolization.
     Ann Nucl Med. 2024;38:210-218.
     PubMed     Abstract available
     
     
     February 2024
168. OKIZAKI A, Nishiyama Y, Inui Y, Otsuka H, et al
     Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
     Ann Nucl Med. 2024 Feb 29. doi: 10.1007/s12149-024-01905.
     PubMed     Abstract available
     
     
     
169. KANEKO K, Nagao M, Ueda K, Yamamoto A, et al
     Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor (11)C-methionine PET/CT imaging.
     Ann Nucl Med. 2024 Feb 22. doi: 10.1007/s12149-024-01908.
     PubMed     Abstract available
     
     
     
170. HONG Z, Xu H, Ni K, Yang Y, et al
     Effect of Cyclosporin H on ischemic injury and neutrophil infiltration in cerebral infarct model of rats via PET imaging.
     Ann Nucl Med. 2024 Feb 15. doi: 10.1007/s12149-024-01900.
     PubMed     Abstract available
     
     
     
171. NIITSU H, Fukumitsu N, Tanaka K, Mizumoto M, et al
     Methyl-(11)C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.
     Ann Nucl Med. 2024 Feb 14. doi: 10.1007/s12149-024-01901.
     PubMed     Abstract available
     
     
     
172. AMIRI A, Fazaeli Y, Zare H, Eslami-Kalantari M, et al
     Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor.
     Ann Nucl Med. 2024 Feb 12. doi: 10.1007/s12149-024-01902.
     PubMed     Abstract available
     
     
     
173. SINGHAL T, Singh P, Parida GK, Agrawal K, et al
     Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
     Ann Nucl Med. 2024 Feb 10. doi: 10.1007/s12149-024-01904.
     PubMed     Abstract available
     
     
     
174. MARUYAMA H, Gomi M, Lwin TT, Yoneyama A, et al
     [(18)F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique.
     Ann Nucl Med. 2024;38:120-130.
     PubMed     Abstract available
     
     
     January 2024
175. TAMURA K, Nishii R, Tani K, Hashimoto H, et al
     A first-in-man study of [(18)F] FEDAC: a novel PET tracer for the 18-kDa translocator protein.
     Ann Nucl Med. 2024 Jan 29. doi: 10.1007/s12149-023-01895.
     PubMed     Abstract available
     
     
     
176. SINGH SB, Bhandari S, Bhandari S, Bhandari S, et al
     Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
     Ann Nucl Med. 2024 Jan 26. doi: 10.1007/s12149-023-01896.
     PubMed     Abstract available
     
     
     
177. HOTTA M, Sonni I, Thin P, Nguyen K, et al
     Visual and whole-body quantitative analyses of (68) Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with (177)Lu-DOTATATE.
     Ann Nucl Med. 2024 Jan 22. doi: 10.1007/s12149-023-01899.
     PubMed     Abstract available
     
     
     
178. DERAKHSHAN S, Ghaderi B, Roshani D
     Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI.
     Ann Nucl Med. 2024 Jan 20. doi: 10.1007/s12149-023-01897.
     PubMed     Abstract available
     
     
     
179. AN R, Ma X, Wang Y
     The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
     Ann Nucl Med. 2024 Jan 13. doi: 10.1007/s12149-023-01892.
     PubMed     Abstract available
     
     
     
180. LI T, Dou J, Zhang H, Su X, et al
     Optimized gated a SPECT-derived myocardial salvage index: its prognostic significance in predicting major adverse cardiac events following acute myocardial infarction percussion.
     Ann Nucl Med. 2024 Jan 4. doi: 10.1007/s12149-023-01894.
     PubMed     Abstract available
     
     
     
181. TAMAKI N, Manabe O
     Current status and perspectives of nuclear cardiology.
     Ann Nucl Med. 2024;38:20-30.
     PubMed     Abstract available
     
     
     
182. NAKAJIMA K, Miyauchi H, Hirano KI, Fujimoto S, et al
     Practice recommendation for measuring washout rates in (123)I-BMIPP fatty acid images.
     Ann Nucl Med. 2024;38:1-8.
     PubMed     Abstract available
     
     
     December 2023
183. KAWAKUBO M, Nagao M, Kaimoto Y, Nakao R, et al
     Deep learning approach using SPECT-to-PET translation for attenuation correction in CT-less myocardial perfusion SPECT imaging.
     Ann Nucl Med. 2023 Dec 28. doi: 10.1007/s12149-023-01889.
     PubMed     Abstract available
     
     
     
184. LIN JT, Li XM, Zhong WZ, Hou QY, et al
     Impact of preoperative [(18)F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
     Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01888.
     PubMed     Abstract available
     
     
     
185. CUI FB, Lv X, Yan CL, Eng WS, et al
     Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.
     Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01893.
     PubMed     Abstract available
     
     
     November 2023
186. PACELLA S, Grappeja L
     Prognostic value of pre-treatment 18F-FDG PET/CT parameters in endometrial cancer.
     Ann Nucl Med. 2023 Nov 27. doi: 10.1007/s12149-023-01887.
     PubMed    
     
     
     
187. SHINOHARA Y, Ibaraki M, Matsubara K, Sato K, et al
     Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
     Ann Nucl Med. 2023 Nov 21. doi: 10.1007/s12149-023-01886.
     PubMed     Abstract available
     
     
     
188. SANAAT A, Amini M, Arabi H, Zaidi H, et al
     The quest for multifunctional and dedicated PET instrumentation with irregular geometries.
     Ann Nucl Med. 2023 Nov 12. doi: 10.1007/s12149-023-01881.
     PubMed     Abstract available
     
     
     
189. PERERA MOLLIGODA ARACHCHIGE AS
     Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight.
     Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01882.
     PubMed    
     
     
     
190. WATANABE S, Hirata K, Magota K, Takenaka J, et al
     Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET.
     Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01884.
     PubMed     Abstract available
     
     
     
191. SHAMIM SA, Kumar N, Arora G, Jaswal S, et al
     A prospective study of (68)Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential (177)Lu-PSMA therapy.
     Ann Nucl Med. 2023 Nov 6. doi: 10.1007/s12149-023-01876.
     PubMed     Abstract available
     
     
     October 2023
192. MICHALSKI K, Kosmala A, Werner RA, Serfling SE, et al
     Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy.
     Ann Nucl Med. 2023 Oct 27. doi: 10.1007/s12149-023-01874.
     PubMed     Abstract available
     
     
     
193. NAKAMOTO Y, Baba S, Kaida H, Manabe O, et al
     Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.
     Ann Nucl Med. 2023 Oct 20. doi: 10.1007/s12149-023-01873.
     PubMed     Abstract available
     
     
     
194. MAKINO A, Kume K, Mori T, Tsujikawa T, et al
     High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography.
     Ann Nucl Med. 2023 Oct 19. doi: 10.1007/s12149-023-01877.
     PubMed     Abstract available
     
     
     
195. NITTA N, Yoshimatsu R, Iwasa H, Nakaji K, et al
     Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT.
     Ann Nucl Med. 2023 Oct 18. doi: 10.1007/s12149-023-01875.
     PubMed     Abstract available
     
     
     
196. MIYAJI N, Miwa K, Yamashita K, Motegi K, et al
     Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm.
     Ann Nucl Med. 2023 Oct 5. doi: 10.1007/s12149-023-01870.
     PubMed     Abstract available
     
     
     
197. LIU C, Ma G, Zhang J, Cheng J, et al
     (18)F-FES and (18)F-FDG PET/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4/6 kinase inhibitors with endocrine treatment.
     Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01871.
     PubMed     Abstract available
     
     
     
198. GUNER LA, Unal K, Beylergil V, Tuna MB, et al
     Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.
     Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01864.
     PubMed     Abstract available
     
     
     September 2023
199. SADEGHI MH, Sina S, Alavi M, Giammarile F, et al
     The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [(18)F]FDG PET/CT examinations.
     Ann Nucl Med. 2023 Sep 28. doi: 10.1007/s12149-023-01867.
     PubMed     Abstract available
     
     
     
200. KIDERA E, Koyasu S, Hirata K, Hamaji M, et al
     Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using (18)F-FDG PET.
     Ann Nucl Med. 2023 Sep 27. doi: 10.1007/s12149-023-01866.
     PubMed     Abstract available
     
     
     
201. HIRATA K, Kamagata K, Ueda D, Yanagawa M, et al
     From FDG and beyond: the evolving potential of nuclear medicine.
     Ann Nucl Med. 2023 Sep 25. doi: 10.1007/s12149-023-01865.
     PubMed     Abstract available
     
     
     
202. SUN X, Yao X, Zeng B, Zhu L, et al
     Association of mismatch repair deficiency in endometrial cancer with (18)F-FDG PET/CT and clinicopathological features and their prognostic value.
     Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01869.
     PubMed     Abstract available
     
     
     
203. LIU Z, Daniels T, Campen MJ, Alvidrez RIM, et al
     Inflammatory atherosclerotic plaque identification by SPECT/CT imaging of LFA-1 using [(111)In] In-DANBIRT in a novel dyslipidemic rat model.
     Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01868.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.